CYTK vs DYN Stock Comparison

DYN currently leads CYTK in this stock comparison, with AIQ scores of 48 vs 40. The clearest difference is momentum, while CYTK has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 8 points
CYTK
Healthcare
vs
DYN
Healthcare
CYTK
Cytokinetics, Incorporated
Price
$56.13
Day move
-0.05%
AIQ Score
40/100
Best edge
Risk Resilience
Sector
Healthcare
DYN
Dyne Therapeutics, Inc.
Leads
Price
$17.16
Day move
+0.88%
AIQ Score
48/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between CYTK and DYN?

DYN leads the current stock comparison as Dyne Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Cytokinetics, Incorporated vs Dyne Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

DYN leads

DYN leads by 8 AIQ points, primarily on Momentum, having only recently taken the lead back from CYTK.

Fragile: 3 of 5 evidence groups support DYN, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Reversed
CYTK

Cytokinetics, Incorporated

AIQ Score
40/100
AIQ Edge Score
2/10
DYN

Dyne Therapeutics, Inc.

Leads
AIQ Score
48/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors DYN over CYTK, 48 versus 40 as of Nov 15, 2026. DYN's advantage is driven primarily by stronger momentum, while CYTK holds the stronger risk resilience profile. DYN also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor DYN today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. DYN lead: Reversed — CYTK led by 2 AIQ points 30 sessions ago; DYN now leads by 8.

Compare Cytokinetics, Incorporated and Dyne Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

CYTK
+42.9%
DYN
+15.1%

Price return comparison

Growth of $10,000, price only

CYTK $14,293 · DYN $11,509

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare CYTK and DYN against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

CYTK advantage
0
DYN advantage
  • Momentum28 vs 52
    DYN +24
  • Risk Resilience56 vs 42
    CYTK +14
  • Quality46 vs 47
    Even

3 of 5 evidence groups favor DYN. DYN’s edge is concentrated in momentum; CYTK keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

CYTK-1 AIQ

Largest factor move: Momentum -3

New signals

  • 52-Week Low Proximity — bearish, risk_regime, long horizon (3.0%)
DYN+1 AIQ

Largest factor move: Momentum +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)

DYN's lead widened by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — CYTK and DYN both carry a full feed there.

The central trade-off

DYN (Dyne Therapeutics, Inc.): the stronger current systematic profile, led by momentum.

CYTK (Cytokinetics, Incorporated): the counter-case, on risk resilience, fundamentals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

DYN

DYN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

CYTK

CYTK on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

DYN

DYN on the Momentum factor, by 24 points.

Lower downside

CYTK

CYTK on Risk Resilience, by 14 points.

Analyst upside

DYN

DYN on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureCYTKDYNNote
Implied upside to target+77%+114.9%DYN has more room
Target dispersion+32.2%+65.1%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2217Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor DYN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreDYN40 vs 48
FundamentalsCYTKEPS growth 8.7% vs 1.9%; TTM ROE 59.2% vs -20.8%
ValuationNot coveredNot covered
TechnicalsDYNPrice vs 50-day -12.5% vs 1.2%; vs 200-day -19.6% vs -11.2%
Risk ResilienceCYTKRisk Resilience 56 vs 42
Analyst expectationsDYNTarget upside 77% vs 114.9%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CYTK and DYN and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 8 points.
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)
  • Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DYN.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

DYN lead: Reversed — CYTK led by 2 AIQ points 30 sessions ago; DYN now leads by 8.

May 27CYTK leads above the line · DYN leads belowNov 13
Today
DYN +8
40 vs 48
7 sessions ago
DYN +6
41 vs 47
30 sessions ago
CYTK +2
45 vs 43
90 sessions ago
DYN +12
52 vs 64

The lead changed hands once in this window, most recently on Jul 13 when DYN moved ahead of CYTK.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

CYTK

0 bullish / 3 bearish / 1 neutral

Only CYTK

  • 52-Week Low Proximity — bearish, risk_regime, long horizon (3.0%)
  • Downtrend Structure Active — bearish, trend, long horizon
DYNConflicted

1 bullish / 3 bearish / 2 neutral, conflicted

Only DYN

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 2 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode.

DYN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

CYTKNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.05%, AIQ -1 points).

DYNConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.88%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CYTK closes the Momentum gap — currently 24 points behind, the largest single contributor to DYN's edge.
  2. 2CYTK's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3DYN's conflicting signal state resolves bearish — it currently carries 1 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

CYTK leads on balance
MetricCYTKDYN
Revenue growth (YoY)66.1%0%
EPS growth (YoY)8.7%1.9%
Gross margin91%0%
Operating margin-6.3%0%
Return on equity (TTM)59.2%-20.8%
Debt to equity-3.960.26

Performance

Split across windows
MetricCYTKDYN
1 week (5 sessions)4.5%-5%
1 month (20 sessions)-9.4%20.4%
3 months (63 sessions)-26%-34.4%
6 months (126 sessions)-26%-0.8%
Year to date-11.7%-12.3%
1 year (252 sessions)-14.9%-7.8%

Technicals

DYN has the stronger structure
MetricCYTKDYN
RSI (14)38.249.3
ADX (14)25.720.9
Price vs 50-day-12.5%1.2%
Price vs 200-day-19.6%-11.2%
Volatility (1M, annualized)57%62.6%

Risk

CYTK is the more resilient
MetricCYTKDYN
Beta1.011.71
Sharpe ratio-0.230.11
Sortino ratio-0.320.16
Max drawdown-38.5%-46.8%
Current drawdown-35.7%-35.9%
Annualized volatility43.7%63.9%
Value at risk (95%)-4%-5.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, CYTK or DYN?

On the Algovestiq AIQ Score, DYN is the stronger of the two as of Nov 15, 2026, scoring 48 against CYTK's 40. The edge comes from momentum. CYTK is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is CYTK or DYN the better buy right now?

DYN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.

Why does the AIQ Score favor DYN over CYTK?

The composite weights Quality, Value, Momentum and Risk Resilience. DYN leads Momentum by 24 points; CYTK leads Risk Resilience by 14 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, CYTK or DYN?

Analyst price targets imply +77% upside for CYTK and +114.9% for DYN, so the Street currently favors DYN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, CYTK or DYN?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, CYTK or DYN?

CYTK on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, CYTK or DYN?

DYN on the Momentum factor, by 24 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, CYTK or DYN?

CYTK is the more resilient of the two, so the other name carries the higher downside risk. CYTK on Risk Resilience, by 14 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is CYTK more profitable than DYN?

CYTK leads on the comparable margin measures — gross margin 91% vs 0%; operating margin -6.3% vs 0%; ttm roe 59.2% vs -20.8%.

Is DYN's lead over CYTK getting stronger or weaker?

DYN lead: Reversed — CYTK led by 2 AIQ points 30 sessions ago; DYN now leads by 8. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-07-13, when DYN moved ahead of CYTK.

What would change the CYTK vs DYN verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CYTK closes the Momentum gap — currently 24 points behind, the largest single contributor to DYN's edge; CYTK's Death Cross Active resolves — a bearish trend rule currently active against it; DYN's conflicting signal state resolves bearish — it currently carries 1 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about CYTK and DYN?

CYTK: 0 bullish / 3 bearish / 1 neutral. DYN: 1 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CYTK is Death Cross Active (bearish, long horizon). On DYN it is Death Cross Active (bearish, long horizon).

Compare CYTK and DYN with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.